P

    Praxis Precision Medicines Inc (PRAX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $350.30
    +5.55 (+1.61%)

    Market Cap: $9.78B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    42%(10/24)
    Avg Surprise
    -9.54%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-3.63
    Range$-5.60 - $-2.74
    17 analysts
    EPS Revisions
    2
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-4.00-10.2%
    60d ago$-4.03-10.8%
    30d ago$-4.03-10.9%
    7d ago$-3.63-0.1%
    Current$-3.63
    Revenue Consensus
    $0
    Range$0 - $0
    16 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-2.93
    Range$-8.83 - $-1.07
    17 analysts
    Revenue Consensus
    $876860
    Range$0 - $7M
    18 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-2.93---
    Sep 26EST
    		-$-3.63---
    Jun 26
    Reported Aug 3
    		$-2.87$-3.60+20.28%Beat+13.3%
    Mar 26
    Reported May 7
    		$-3.20$-3.68+13.04%Beat+2.7%
    Dec 25
    Reported Feb 19
    		$-3.50$-3.13-11.82%Miss-19.0%
    Sep 25
    Reported Nov 5
    		$-3.36$-3.45+2.61%Beat-22.2%
    Jun 25
    Reported Aug 4
    		$-3.31$-3.36+1.49%Beat-90.2%
    Mar 25
    Reported May 2
    		$-3.29$-3.21-2.49%Miss-15.8%
    Dec 24
    Reported Feb 28
    		$-2.94$-2.82-4.29%Miss+1.0%
    Sep 24
    Reported Nov 6
    		$-2.75$-1.95-41.03%Miss-1.9%
    Jun 24
    Reported Aug 13
    		$-1.74$-2.32+25.00%Beat+76.3%
    Mar 24
    Reported May 13
    		$-2.84$-2.16-31.48%Miss+73.3%
    Dec 23
    Reported Mar 5
    		$-2.97$-3.18+6.60%Beat+77.2%
    Sep 23
    Reported Nov 7
    		$-2.70$-4.89+44.79%Beat+81.2%
    Jun 23
    Reported Aug 9
    		$-7.35$-10.60+30.66%Beat+62.9%
    Mar 23
    Reported May 11
    		$-10.65$-12.80+16.80%Beat-605.3%
    Dec 22
    Reported Feb 7
    		$-13.05$-12.03-8.48%Miss+33.1%
    Sep 22
    Reported Nov 9
    		$-14.40$-14.01-2.78%Miss+4.0%
    Jun 22
    Reported Aug 8
    		$-19.80$-19.27-2.75%Miss-50.0%
    Mar 22
    Reported May 9
    		$-1.51$-1.30-16.15%Miss+85.8%
    Dec 21
    Reported Feb 28
    		$-19.50$-16.05-21.50%Miss-2141.4%
    Sep 21
    Reported Nov 3
    		$-15.00$-13.95-7.53%Miss-89.9%
    Jun 21
    Reported Aug 16
    		$-13.20$-10.12-30.43%Miss-238.5%
    Mar 21
    Reported May 11
    		$-10.65$-11.14+4.40%Beat-
    Dec 20
    Reported Mar 17
    		$-0.87$-0.37-135.14%Miss-
    Sep 20
    Reported Oct 16
    		$-7.90$-4.42-78.73%Miss-
    Jun 20
    Reported Sep 2
    		$-3.90$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-27.09EV/EBITDA-6.86x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-38.90%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio15.73xQuick Ratio15.73x
    Trading Statistics
    Beta2.78Avg Volume424.64K
    52-Week High$392.7052-Week Low$37.19

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$367.29
    SMA 20$363.44
    SMA 50$335.66
    SMA 200$304.52
    EMA 10$362.11
    EMA 20$357.41
    EMA 50$340.51
    EMA 200$285.61

    MACD

    Line: 8.68Signal: 12.66Hist: -3.97

    ADX

    ADX: 29.6+DI: 22.2-DI: 21.0

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down8.0
    PSAR$389.64

    Bollinger Bands

    Upper Band$402.21
    Lower Band$324.66
    %B Position2134%(Upper)
    Band Width0.33

    RSI (14-Day)

    Neutral
    49.2

    Momentum Oscillators

    Stoch %K21.1
    Stoch %D34.9
    Williams %R-71.6
    ROC (10d)-6.9%
    Momentum-26.08
    CCI (20d)-92.0
    MFI (14d)53.5

    Volatility Measures

    ATR (14d)$19.99(5.7%)
    StdDev (20d)19.39
    Hist Vol75.7%(High)

    Volume Flow

    VWAP$345.16
    OBV27.8M
    AD Line-11.3M
    CMF (20d)0.163

    Volume Metrics

    Avg Vol (20d)430.1K
    Vol Ratio0.8x
    VWMA (20d)$366.06

    Pivot Points

    R3$383.08
    R2$375.39
    R1$360.07
    Pivot Point$352.38
    S1$337.06
    S2$329.37
    S3$314.05

    Advanced Oscillators

    TSI11.82
    Ultimate Osc45.7
    KST145.93

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$7.46M$302,000$357,000$431,000$515,000$468,000
    Cost of Revenue$0$0$28,000$0$0$0$56.29M$0$0$0$18.39M$0
    Gross Profit$0$0$-28,000$0$0$0$7.46M$302,000$357,000$431,000$515,000$468,000
    Operating Expenses$96.90M$105.86M$97.04M$78.36M$76.07M$74.73M$71.42M$57.14M$37.84M$42.32M$28.32M$25.98M
    R&D$69.42M$77.99M$77.51M$65.80M$63.01M$60.81M$56.29M$41.88M$27.26M$26.98M$18.39M$17.26M
    SG&A$27.49M$27.87M$19.54M$12.56M$13.06M$13.92M$15.13M$15.26M$10.59M$15.33M$9.93M$8.72M
    Operating Income$-96,904,000$-105,860,000$-97,044,000$-78,359,000$-76,067,000$-74,728,000$-63,956,000$-56,835,000$-37,488,000$-41,886,000$-27,806,000$-25,516,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-83,720,000$-92,561,000$-88,911,000$-73,934,000$-71,127,000$-69,296,000$-58,679,000$-51,910,000$-32,677,000$-39,553,000$-26,878,000$-24,632,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-83,720,000$-92,561,000$-88,911,000$-73,934,000$-71,127,000$-69,296,000$-58,679,000$-51,910,000$-32,677,000$-39,553,000$-26,878,000$-24,632,000
    EBITDA$-84,376,000$-93,177,000$-89,554,000$-74,620,000$-72,068,000$-70,478,000$-60,022,000$-53,823,000$-34,101,000$-39,525,000$-26,767,000$-24,523,000
    EBIT$-83,720,000$-92,561,000$-88,911,000$-73,934,000$-71,127,000$-69,296,000$-58,679,000$-51,910,000$-32,677,000$-39,553,000$-26,878,000$-24,632,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PRAX

    News

    Breakeven On The Horizon For Praxis Precision Medicines, Inc. (NASDAQ:PRAX)

    This article analyzes Praxis Precision Medicines, Inc. (NASDAQ:PRAX) and discusses its path to profitability. It focuses on the company's financial performance, analyst expectations regarding its breakeven point, and the potential for future growth.

    Moomoo•8/23/26•
    Bullish

    Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $575

    Goldman Sachs has reiterated its Buy rating for Praxis Precision Medicines (PRAX.US) and increased its target price for the company to $575. This indicates a positive outlook from the investment bank regarding the company's future performance.

    Moomoo•8/20/26•
    Bullish

    Praxis Precision Medicine Number of Employees 2026 | Employee Count & Headcount Data

    Praxis Precision Medicines, Inc. (PRAX) had 208 employees worldwide as of March 2026, representing a 120.6% growth from 94 employees in 2023. The company, headquartered in Boston, Massachusetts, is actively hiring with 81 job postings in 2026, a 117.6% increase from the previous year. While overall employee sentiment is negative, it shows improvement, and the average salary is $162,227, though it experienced a 3.3% year-over-year decrease in 2026.

    Revelio Labs•8/19/26•
    Somewhat-Bullish

    Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $650

    Oppenheimer has reiterated its Buy rating for Praxis Precision Medicines (PRAX.US) and maintained its target price at $650. This indicates a continued positive outlook from the firm regarding the company's stock performance.

    Moomoo•8/18/26•
    Bullish

    Praxis Precision Medicines stock hits 52-week high at 388.27 USD

    Praxis Precision Medicines Inc. (PRAX) stock has reached a new 52-week high of $388.27, representing a 721.64% increase over the past year. Despite the impressive growth and investor confidence, InvestingPro data suggests the stock may be overvalued and highly volatile. The company recently reported a narrower-than-expected loss for Q2 2026 and received an increased price target from Raymond James, citing confidence in its EMERALD trial and future drug launches.

    Investing.com•8/18/26•
    Bullish

    Frequently Asked Questions About PRAX

    Does PRAX pay dividends?
    Praxis Precision Medicines Inc (PRAX) does not currently pay a regular dividend.
    What is PRAX's market cap?
    Praxis Precision Medicines Inc (PRAX) has a market capitalization of $9.78B with a current stock price of $350.30.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In